Skip navigation
Merrion pharmaceuticals - making medicines better
Skip navigation

Press Releases / Publications

Download Adobe Acrobat Reader Some of the articles are in PDF format. You will need Adobe Acrobat Reader to view them. Click on the logo to download it for free.

2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006/04


December Therapeutic Focus: Weekly, Oral Zoledronic Acid can Improve Quality of Life for Bone Metastases Sufferers - By Cindy Dubin, Drug Delivery Technology, Dec 2010
December Merrion ends an active 2010 on agreement with Novo Nordisk
December Merrion Pharmaceuticals Plc signs Collaboration and Option agreement and Warrant agreement with Novo Nordisk
December Merrion Pharmaceuticals Plc signs Feasibility and Option agreement for 3 drugs with International ‘top ten‘ Pharmaceutical Company
November Merrion Pharmaceuticals Plc announces commencement of feasibility and option agreement with Rebel Pharmaceuticals
November Merrion finalises its Phase III development program for Orazol™ in the USA
November Merrion Pharmaceuticals Collaboration with Novo Nordisk - Keynote presentation at the Life Sciences International Summit 2010, Croke Park, Dublin
November Merrion Pharmaceuticals to present Oral Fondaparinux data at the 2010 AAPS Meeting & Exhibition, New Orleans Wed 17th Nov 2010
November Merrion Pharmaceuticals Announces Participation in Science Week Corporate Partners Programme 2010
September Game Changer, Life Science Review, Sept 2010
September Merrion Pharmaceuticals Selected to present at UBS 2010 Global Life Sciences Conference in New York
September Merrion Pharmaceuticals Plc Announces Participation at the Roche Colorado Corporation Peptide Symposium, Wednesday 15th Sept 2010
September Merrion Pharmaceuticals plc Interim Results for the six months ended 30 June 2010
August ‘Developing Oral Forms of Poorly Absorbed Drugs‘ - Merrion Pharmaceuticals feature in SP2, Discovery and Development for Life Sciences, August 2010 Edition. (page 28 of web article)
July Merrion Pharmaceuticals new facility is granted license to manufacture by Irish Medicines Board
June Merrion Pharmaceuticals to present at UBS 2010 Global Specialty Pharmaceuticals Conference in London
May Merrion Pharmaceuticals: Validating Oral Delivery, Drug Delivery Executive, Drug Delivery Technology, May 2010
May Merrion Pharmaceuticals Appoints Dr. Hing Kin Chan as Chief Business Officer
May Merrion Pharmaceuticals is issued a key US patent for Orazol™
April Novo Nordisk starts Phase I trial with oral GLP1 analogue using Merrion Pharmaceutical's GIPET® technology
March Merrion Pharmaceuticals Plc Announces Preliminary Results for the year ended 31 Dec 2009.
March Merrion Pharmaceuticals plc announces issuance of key United States Patent, 2nd March 2010.
January MERRION PHARMACEUTICALS Announces Participation at the 14th Annual Drug Delivery Partnerships, Orlando, Florida.

Presentation Wednesday 27th January 2010 ‘Partnering in Oral Drug Delivery of Therapeutic Polypeptides for the Treatment of Diabetes- the Novo Nordisk A/S- Merrion Collaboration‘